LSBCF
LakeShore Biopharma Co., Ltd.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D/A | 6/25/2026 | View on SEC |
| 15-12G | 6/24/2026 | View on SEC |
| S-8 POS | 6/24/2026 | View on SEC |
| S-8 POS | 6/24/2026 | View on SEC |
| SC 13E3/A | 6/24/2026 | View on SEC |
| 6-K | 6/24/2026 | View on SEC |
| 6-K | 6/22/2026 | View on SEC |
| 6-K | 5/28/2026 | View on SEC |
| SC 13E3/A | 5/28/2026 | View on SEC |
| SC 13E3/A | 5/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LSBCF |
| Company Name | LakeShore Biopharma Co., Ltd. |
| CIK | 1946399 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Emerging growth company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 0331 |
| State of Incorporation | E9 |
| Phone | 17327133678 |